Chemkart India IPO Upcoming
Already have an account? Apply now
Schedule of Chemkart India
| Issue open date | 07 Jul 2025 |
| Issue close date | 09 Jul 2025 |
| UPI mandate deadline | 09 Jul 2025 (5 PM) |
| Allotment finalization | 10 Jul 2025 |
| Refund initiation | 11 Jul 2025 |
| Share credit | 11 Jul 2025 |
| Listing date | 14 Jul 2025 |
| Mandate end date | 24 Jul 2025 |
| Lock-in end date for anchor investors (50%) | 09 Aug 2025 |
| Lock-in end date for anchor investors (remaining) | 08 Oct 2025 |
Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.
About Chemkart India
Established in 2020, Chemkart India Limited is a Mumbai-based nutritional and health supplement company specializing in Business-to-Business operations. The company supplies raw materials and processed components to manufacturers of finished supplements across seven main product categories: Amino Acids, Health Supplements, Herbal Extract, Nucleotide, Protein, Sports Nutrition, and Vitamins.
Operating from Mumbai with a 28,259 sq. ft. warehouse facility in Bhiwandi, Thane, Chemkart India maintains processing capabilities with 1.8 MT per day grinding capacity and 1.5 MT per day blending capacity. The company specializes in customer-specific processing of amino acids and other raw materials, enabling manufacturers to create tailored supplement formulations.
With revenue growing at a CAGR of 24.39% from FY 2023 to FY 2025, Chemkart India Limited focuses on quality, variety, and convenience to meet the evolving nutritional needs of its B2B customers in the supplement manufacturing industry.
Financials of Chemkart India
Issue size
| Funds Raised in the IPO | Amount |
| Overall | ₹80.18 crores |
| Fresh Issue | ₹64.48crores |
| Offer for sale | ₹15.60 crores |
Utilisation of proceeds
| Purpose | INR crores (%) |
| Funding capital expenditure | 34.68 (53.78%) |
| Repayment/prepayment of outstanding borrowings | 20.00 (31.02%) |
| General corporate purposes | – |
Strengths
- Diversified nutraceutical portfolio across key categories supports broad customer reach.
- In-house facility enables hygienic blending, grinding, and packaging with trained staff.
- Strong B2B ties drive long-term value in the nutraceutical space.
- Strategic location near Mumbai port enables efficient port-to-warehouse logistics.
- Early trend identification enables faster product launches and first-mover advantage in the Indian market.
Risks
- Dependence on few suppliers without contracts may disrupt operations.
- Heavy reliance on Chinese imports exposes the business to geopolitical and supply chain risks.
- Limited experience in nutraceutical may affect compliance, growth, and market response.
- Loss of rented office space may disrupt operations and increase costs.
- No long-term contracts and high customer dependence may impact revenue stability.
- Related party transactions may impact business and financial performance.
- Recent negative cash flows may affect growth and stability.
Allotment Status for Chemkart India
To check your allotment status – click here.